bullish

Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU): Illuccix Launched in US; Large Market Opportunity; Potential to Grow

Telix has launched Illuccix in the U.S., having a billion-dollar market opportunity. The company is progressing toward launch of the product in other countries including APAC, Europe, and Canada.

Equity Bottom-Up
188 Views, 15 Aug 2022 15:25
SUMMARY
or

Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
x